相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Adaptive immune response to Clostridium difficile infection: A perspective for prevention and therapy
William D. Rees et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Clostridium difficile Toxoid Vaccine Candidate Confers Broad Protection against a Range of Prevalent Circulating Strains in a Nonclinical Setting
Laurence Quemeneur et al.
INFECTION AND IMMUNITY (2018)
Changes in Prevalence of Health Care-Associated Infections in US Hospitals
S. S. Magill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
M. H. Wilcox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Risk factors for Clostridium difficile infections-an overview of the evidence base and challenges in data synthesis
Paul Eze et al.
JOURNAL OF GLOBAL HEALTH (2017)
Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence
Swati B. Gupta et al.
CLINICAL INFECTIOUS DISEASES (2016)
Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial
Guy de Bruyn et al.
VACCINE (2016)
Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing
David W. Eyre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Nomenclature for Immune Correlates of Protection After Vaccination
Stanley A. Plotkin et al.
CLINICAL INFECTIOUS DISEASES (2012)
Burden of Clostridium difficile on the Healthcare System
Erik R. Dubberke et al.
CLINICAL INFECTIOUS DISEASES (2012)
Phase I dose finding studies of an adjuvanted Clostridium difficile toxoid vaccine
Richard N. Greenberg et al.
VACCINE (2012)
Clostridium difficile: Development of a novel candidate vaccine
Ginamarie Foglia et al.
VACCINE (2012)
The Search for Effective Treatment of Clostridium difficile Infection
Herbert L. DuPont
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)
Brett A. Leav et al.
VACCINE (2010)
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Maja Rupnik et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Clinical recognition and diagnosis of Clostridium difficile infection
John G. Bartlett et al.
CLINICAL INFECTIOUS DISEASES (2008)
Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates
T Åkerlund et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Revised nomenclature of Clostridium difficile toxins and associated genes
M Rupnik et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2005)
Treatment of Clostridium difficile-associated disease: old therapies and new strategies
S Aslam et al.
LANCET INFECTIOUS DISEASES (2005)
Breaking the cycle:: Treatment strategies for 163 cases of recurrent Clostridium difficile disease
LV McFarland et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2002)
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea
L Kyne et al.
LANCET (2001)
Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
L Kyne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)